ImmunityBio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 16.90 M | $62.88 M | 22.20% | 2.43% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 11.86 M | $44.11 M | 100.00% | 1.70% |
STATE STREET CORP | 11/14/2024 | 8.65 M | $32.19 M | 10.05% | 1.24% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.85 M | $14.31 M | -1.81% | 0.55% |
MORGAN STANLEY | 11/14/2024 | 2.25 M | $8.36 M | 295.30% | 0.32% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.07 M | $7.70 M | 115.93% | 0.30% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.29 M | $4.79 M | 25.75% | 0.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.27 M | $4.71 M | 2.40% | 0.18% |
JPMORGAN CHASE & CO | 11/08/2024 | 1.14 M | $4.24 M | -3.59% | 0.16% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.12 M | $4.15 M | 1,093.24% | 0.16% |
FIRST TRUST ADVISORS LP | 11/13/2024 | 756,809 | $2.82 M | -14.74% | 0.11% |
ALLEN HOLDING INC /NY | 11/07/2024 | 687,571 | $2.56 M | 0.00% | 0.10% |
SHEETS SMITH WEALTH MANAGEMENT | 11/01/2024 | 665,995 | $2.48 M | 0.00% | 0.10% |
JANE STREET GROUP, LLC | 11/15/2024 | 664,100 | $2.47 M | 100.00% | 0.10% |
ACCURATE WEALTH MANAGEMENT, LLC | 10/17/2024 | 560,000 | $2.07 M | 0.00% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 536,700 | $2.00 M | 5.75% | 0.08% |
D. E. SHAW & CO., INC. | 11/14/2024 | 520,053 | $1.93 M | 100.00% | 0.07% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 505,321 | $1.88 M | -18.70% | 0.07% |
CITADEL ADVISORS LLC | 11/14/2024 | 504,700 | $1.88 M | -0.75% | 0.07% |
CLEARWATER CAPITAL ADVISORS, LLC | 11/12/2024 | 482,549 | $1.80 M | 0.00% | 0.07% |
RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 455,705 | $1.70 M | 4.60% | 0.07% |
CI PRIVATE WEALTH, LLC | 11/12/2024 | 446,460 | $1.66 M | 101.04% | 0.06% |
WOODLINE PARTNERS LP | 11/14/2024 | 439,818 | $1.64 M | 0.45% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 418,057 | $1.56 M | 10.28% | 0.06% |
UBS GROUP AG | 11/14/2024 | 406,433 | $1.51 M | -11.31% | 0.06% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 403,528 | $1.50 M | 0.00% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 387,100 | $1.44 M | -39.14% | 0.06% |
BARCLAYS PLC | 11/19/2024 | 361,036 | $1.34 M | 127.37% | 0.05% |
HARBOURVEST PARTNERS LLC | 11/14/2024 | 335,709 | $1.25 M | 0.00% | 0.05% |
CITADEL ADVISORS LLC | 11/14/2024 | 316,110 | $1.18 M | 45.69% | 0.05% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2024 | 270,950 | $1.01 M | 0.00% | 0.04% |
SWISS NATIONAL BANK | 11/07/2024 | 270,000 | $1.00 M | 2.62% | 0.04% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 261,922 | $1.03 M | 2,276.36% | 0.04% |
SCULPTOR CAPITAL LP | 11/14/2024 | 218,800 | $813,936 | 0.00% | 0.03% |
SCULPTOR CAPITAL LP | 11/14/2024 | 217,800 | $810,216 | 77.80% | 0.03% |
RHUMBLINE ADVISERS | 11/12/2024 | 207,488 | $771,843 | -1.98% | 0.03% |
BLAIR WILLIAM & CO/IL | 11/12/2024 | 206,800 | $769,296 | 0.00% | 0.03% |
CLEARSTEAD ADVISORS, LLC | 11/13/2024 | 206,000 | $766,320 | 9.28% | 0.03% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 205,530 | $764,572 | 0.00% | 0.03% |
SCULPTOR CAPITAL LP | 11/14/2024 | 200,000 | $744,000 | -43.66% | 0.03% |
DEKABANK DEUTSCHE GIROZENTRALE | 10/24/2024 | 196,200 | $782,000 | 0.00% | 0.03% |
FRANKLIN RESOURCES INC | 11/27/2024 | 194,442 | $723,325 | -2.38% | 0.03% |
CITADEL ADVISORS LLC | 11/14/2024 | 162,000 | $602,640 | -52.00% | 0.02% |
LPL FINANCIAL LLC | 11/08/2024 | 153,954 | $572,709 | 27.87% | 0.02% |
11/14/2024 | 153,000 | $601.29 M | 0.00% | 0.02% | |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 142,525 | $529,646 | 0.33% | 0.02% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 135,029 | $502,000 | 100.00% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 10/25/2024 | 133,966 | $498,354 | 64.88% | 0.02% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 131,324 | $488,525 | -0.67% | 0.02% |
ROYAL BANK OF CANADA | 11/14/2024 | 127,536 | $475,000 | -72.88% | 0.02% |
ImmunityBio, Inc.institutional Ownership - FAQ's
During the previous two years, 219 institutional investors and hedge funds held shares of ImmunityBio, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 16.9 M
BlackRock Funding, Inc. /DE: 11.86 M
STATE STREET CORP: 8.65 M
GEODE CAPITAL MANAGEMENT, LLC: 3.85 M
MORGAN STANLEY: 2.25 M
BANK OF AMERICA CORP /DE/: 2.07 M
9.87% of ImmunityBio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 79.36 M shares in the last 24 months. This purchase volume represents approximately $208.70 M in transactions.